Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Abstract Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important to guide preventative treatment and improve outcomes. Blood eosinophil...

Full description

Bibliographic Details
Main Authors: Dave Singh, Jadwiga A. Wedzicha, Salman Siddiqui, Alberto de la Hoz, Wenqiong Xue, Helgo Magnussen, Marc Miravitlles, James D. Chalmers, Peter M. A. Calverley
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Respiratory Research
Subjects:
Eosinophils
Exacerbations
ICS
Rate ratio
Clinically irrelevant
Randomized controlled trials
Online Access:http://link.springer.com/article/10.1186/s12931-020-01482-1

Internet

http://link.springer.com/article/10.1186/s12931-020-01482-1

Similar Items